EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients

ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patientsGlasmacinal, a novel macrolide, was well tolerated ...
Thorax

Blood eosinophil-guided systemic corticosteroid duration in adults hospitalised for asthma exacerbation: a randomised, controlled, open-label, non-inferiority trial

Objective Systemic corticosteroids for 5–7 days are standard care for asthma exacerbations, but the optimal duration and ...
CIDRAP

Single HPV vaccine dose matches protection of 2-dose regimen, new trial shows

Previous trials have shown that a one-dose regimen of the HPV vaccine may be as effective as two- and three-dose regimens, ...

Capricor: Maintaining 'Hold' Rating On Randomized Phase 3 HOPE-3 Trial Win With Deramiocel

Capricor shows positive HOPE-3 results with endpoints met, regulatory uncertainty, and a strong cash runway into 2026. Find ...
The New England Journal of Medicine

Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
Canadian Medical Association Journal

A cluster randomized controlled trial of an electronic medical record–based pathway for pediatric asthma in primary care in Alberta

Background: Primary care physicians, who manage the care of most children with asthma, often do not optimally assess disease control, prescribe asthma controller medications, or provide family asthma ...